Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (HaploSCD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01461837
Recruitment Status : Recruiting
First Posted : October 28, 2011
Last Update Posted : March 13, 2019
Sponsor:
Collaborators:
UCSF Benioff Children’s Hospital Oakland
Medical College of Wisconsin
Washington University School of Medicine
Tufts Medical Center
University of California, San Francisco
University of California, Los Angeles
Miltenyi Biotec GmbH
Lurie Children's Hospital of Chicago
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : December 2019